pSBbi-Neo Citations (8)
Originally described in: Optimized Sleeping Beauty transposons rapidly generate stable transgenic cell lines.Kowarz E, Loescher D, Marschalek R Biotechnol J. 2015 Feb 4. doi: 10.1002/biot.201400821. PubMed Journal
Articles Citing pSBbi-Neo
| Articles |
|---|
| A multi-state model of chemoresistance to characterize phenotypic dynamics in breast cancer. Howard GR, Johnson KE, Rodriguez Ayala A, Yankeelov TE, Brock A. Sci Rep. 2018 Aug 13;8(1):12058. doi: 10.1038/s41598-018-30467-w. PubMed |
| Cancer cell population growth kinetics at low densities deviate from the exponential growth model and suggest an Allee effect. Johnson KE, Howard G, Mo W, Strasser MK, Lima EABF, Huang S, Brock A. PLoS Biol. 2019 Aug 5;17(8):e3000399. doi: 10.1371/journal.pbio.3000399. eCollection 2019 Aug. PubMed |
| CD4 T-cell immune stimulation of HER2 + breast cancer cells alters response to trastuzumab in vitro. Song PN, Mansur A, Dugger KJ, Davis TR, Howard G, Yankeelov TE, Sorace AG. Cancer Cell Int. 2020 Nov 10;20(1):544. doi: 10.1186/s12935-020-01625-w. PubMed |
| Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner. Smith AR, Alonso JA, Ayres CM, Singh NK, Hellman LM, Baker BM. Proc Natl Acad Sci U S A. 2021 Jan 26;118(4). pii: 2018125118. doi: 10.1073/pnas.2018125118. PubMed |
| Tumor rejection properties of gp100209-specific T cells correlate with T cell receptor binding affinity towards the wild type rather than anchor-modified antigen. Alonso JA, Smith AR, Baker BM. Mol Immunol. 2021 Jul;135:365-372. doi: 10.1016/j.molimm.2021.05.001. Epub 2021 May 11. PubMed |
| Quantification of long-term doxorubicin response dynamics in breast cancer cell lines to direct treatment schedules. Howard GR, Jost TA, Yankeelov TE, Brock A. PLoS Comput Biol. 2022 Mar 31;18(3):e1009104. doi: 10.1371/journal.pcbi.1009104. eCollection 2022 Mar. PubMed |
| Quantifying the Effects of Combination Trastuzumab and Radiation Therapy in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Bloom MJ, Song PN, Virostko J, Yankeelov TE, Sorace AG. Cancers (Basel). 2022 Aug 31;14(17):4234. doi: 10.3390/cancers14174234. PubMed |
| A mathematical model for predicting the spatiotemporal response of breast cancer cells treated with doxorubicin. Miniere HJM, Lima EABF, Lorenzo G, Hormuth DA 2nd, Ty S, Brock A, Yankeelov TE. Cancer Biol Ther. 2024 Dec 31;25(1):2321769. doi: 10.1080/15384047.2024.2321769. Epub 2024 Feb 27. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.